BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36683321)

  • 21. Diabetes insipidus.
    Christ-Crain M; Bichet DG; Fenske WK; Goldman MB; Rittig S; Verbalis JG; Verkman AS
    Nat Rev Dis Primers; 2019 Aug; 5(1):54. PubMed ID: 31395885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.
    Moeller HB; Rittig S; Fenton RA
    Endocr Rev; 2013 Apr; 34(2):278-301. PubMed ID: 23360744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nephrogenic diabetes insipidus].
    Evrard A; Lefebvre J; Vantyghem M
    Ann Endocrinol (Paris); 1999 Dec; 60(6):457-64. PubMed ID: 10617799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C; Higgins PJ; Zhang W
    Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive Manner.
    Habiby R; Bichet DG; Arthus MF; Connaughton D; Shril S; Mane S; Majmundar AJ; Hildebrandt F; Robertson GL
    J Clin Endocrinol Metab; 2022 May; 107(6):e2513-e2522. PubMed ID: 35137152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and Management of Central Diabetes Insipidus in Adults.
    Tomkins M; Lawless S; Martin-Grace J; Sherlock M; Thompson CJ
    J Clin Endocrinol Metab; 2022 Sep; 107(10):2701-2715. PubMed ID: 35771962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.
    Duzenli D; Saglar E; Deniz F; Azal O; Erdem B; Mergen H
    Endocrine; 2012 Dec; 42(3):664-9. PubMed ID: 22644838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.
    Bockenhauer D; Bichet DG
    Nat Rev Nephrol; 2015 Oct; 11(10):576-88. PubMed ID: 26077742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrogenic diabetes insipidus: a comprehensive overview.
    Vaz de Castro PAS; Bitencourt L; de Oliveira Campos JL; Fischer BL; Soares de Brito SBC; Soares BS; Drummond JB; Simões E Silva AC
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):421-434. PubMed ID: 35146976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic Diabetes Insipidus.
    Balla A; Hunyady L
    Exp Suppl; 2019; 111():317-339. PubMed ID: 31588538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The laboratory investigation of diabetes insipidus: A review.
    Boot C
    Ann Clin Biochem; 2024 Jan; 61(1):19-31. PubMed ID: 36650746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes insipidus: Differential diagnosis and management.
    Robertson GL
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):205-18. PubMed ID: 27156759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
    Faerch M; Christensen JH; Corydon TJ; Kamperis K; de Zegher F; Gregersen N; Robertson GL; Rittig S
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):395-403. PubMed ID: 17941907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.
    Vergier J; Fromonot J; Alvares De Azevedo Macedo A; Godefroy A; Marquant E; Guieu R; Tsimaratos M; Reynaud R
    Arch Pediatr; 2018 Jan; 25(1):45-47. PubMed ID: 29241593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Accuracy of Copeptin in the Differential Diagnosis of Patients With Diabetes Insipidus: A Systematic Review and Meta-analysis.
    Mu D; Ma Y; Cheng J; Qiu L; Chen S; Cheng X
    Endocr Pract; 2023 Aug; 29(8):644-652. PubMed ID: 37225043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrogenic diabetes insipidus.
    Bichet DG
    Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes Insipidus: New Concepts for Diagnosis.
    Christ-Crain M
    Neuroendocrinology; 2020; 110(9-10):859-867. PubMed ID: 31986514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
    Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
    FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].
    Makretskaya NA; Nanzanova US; Hamaganova IR; Eremina ER; Tiulpakov AN
    Probl Endokrinol (Mosk); 2023 May; 69(2):75-79. PubMed ID: 37448274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.